Home / Moved to Main Board / Kwality Pharmaceuticals
Kwality Pharmaceuticals: IPO, Share Price and Results Since Listing
Kwality Pharmaceuticals moved from BSE SME to the BSE main board. For Q2 FY2027 it reported revenue of INR 181.22 crore (+63.19% on a year earlier) and a profit after tax of INR 29.03 crore.
Key Facts
- Moved to
- BSE main board (BSE does not publish the date)
- Listed on BSE SME
- 18 July 2016
- Symbol
- KPL (BSE code 539997)
- Latest close
- INR 3,824.45 on 13 November 2026
Results Filed With BSE
Consolidated figures, INR crore. Change compares with the same period a year earlier.
| Period | Revenue | Change | Profit after tax | EPS (INR) | Filed | |
|---|---|---|---|---|---|---|
| Q2 FY2027 | 181.22 | +63.19% | 29.03 | 27.93 | after listing | 12 November 2026 |
| Q1 FY2027 | 162.35 | +45.63% | 25.62 | 24.69 | after listing | 10 August 2026 |
| Q4 FY2026 | 157.11 | +35.82% | 25.31 | 24.39 | after listing | 19 May 2026 |
| FY2026 | 503.08 | +35.90% | 67.35 | 64.90 | after listing | 19 May 2026 |
| Q3 FY2026 | 123.44 | – | 16 | 15.42 | after listing | 12 February 2026 |
| Q2 FY2026 | 111.05 | – | 14.12 | 13.60 | after listing | 13 November 2025 |
| Q1 FY2026 | 111.48 | – | 11.92 | 11.49 | after listing | 11 August 2025 |
| Q4 FY2025 | 115.68 | – | 14.48 | 13.95 | after listing | 19 May 2025 |
| FY2025 | 370.20 | – | 39.80 | 38.36 | after listing | 19 May 2025 |
Promoter Holding
Promoter holding has moved from 54.83% on 31 December 2025 to 54.86% on 30 September 2026 (+0.03 percentage points).
| As of | Promoters | Public |
|---|---|---|
| 30 September 2026 | 54.86% | 45.14% |
| 30 June 2026 | 54.86% | 45.14% |
| 31 March 2026 | 54.87% | 45.13% |
| 31 December 2025 | 54.83% | 45.17% |
Sources: BSE filings (results XBRL, shareholding pattern, board meetings), BSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.